Guardant Health Inc at Morgan Stanley Global Healthcare Conference Transcript
I'm Tejas Savant from the life science tools and diagnostics team at Morgan Stanley. It's my pleasure today to host Guardant Health. And from the company, we have Helmy, Amirali and Mike. So thanks, gents, for doing this. Let's kick it off. So maybe, Helmy, just to set the stage, could you share your vision for the company when you started it, where are you in that journey today? One of the things that sort of jumped out to me last Friday at the Analyst Day was how far you've come as a company since we first met sort of all those years ago? What's gone well? And where has progress been slower than you had hoped for?
Questions & Answers
Yes. It's actually very interesting. When we started the company, we had almost exactly the same vision that we've really turned into reality today, 11 years later this idea of really following the continuum of care towards a simple blood test for early detection of cancer,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |